Pediatrix Medical GroupFRA:PDC -0.94%57 FCF Yield % is 11.71 as of Jun. 27, 2026, which is 9% above its 10-year median of 10.72. GuruFocus rates FRA:PDC with a GF Score™ of 57/100 and a GF Value™ of €11.17 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 687 Healthcare Providers & Services companies, Pediatrix Medical Group ranks better than 85.44% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Pediatrix Medical Group's FCF Yield % or its related term are showing as below:
FRA:PDC'
s FCF Yield % Range Over the Past 10 Years
Min: -0.73 Med: 10.72 Max: 43.31
Current: 11.71
During the past 13 years, the highest FCF Yield % of Pediatrix Medical Group was 43.31%. The lowest was -0.73%. And the median was 10.72%.
FRA:PDC's FCF Yield % is ranked better than 85.44% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 1.91
vs FRA:PDC: 11.71
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Pediatrix Medical Group FCF Yield % Related Terms
Pediatrix Medical Group FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:PDC vs SGRY, ADUS, SNDA: FCF Yield % Comparison
For the Medical Care Facilities subindustry, Pediatrix Medical Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pediatrix Medical Group FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pediatrix Medical Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Pediatrix Medical Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pediatrix Medical Group (FRA:PDC) has a FCF Yield % of 11.71 as of Jun. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Pediatrix Medical Group and its competitors. This is near median its historical median of 10.72. According to the industry distribution chart, Pediatrix Medical Group ranks #100 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 14.6%.
Is Pediatrix Medical Group's FCF Yield % too high?
Pediatrix Medical Group's current FCF Yield % of 11.71 is near median its 10-year median of 10.72. The Healthcare Providers & Services industry median FCF Yield % is 1.91. Pediatrix Medical Group's value of 11.71 is 513.1% above this industry median. Based on the distribution chart, Pediatrix Medical Group ranks #100 out of 687 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pediatrix Medical Group has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pediatrix Medical Group's FCF Yield % compare to SGRY and ADUS?
According to the Healthcare Providers & Services industry distribution chart, Pediatrix Medical Group ranks #100 out of 687 companies for FCF Yield %. This places Pediatrix Medical Group in the top 15% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 1.91. Pediatrix Medical Group's value of 11.71 is 513.1% above this benchmark. While the company's 10-year median is 10.72 vs. the industry median of 1.91, Pediatrix Medical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.91, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pediatrix Medical Group's current FCF Yield % of 11.71 is 513.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Pediatrix Medical Group and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pediatrix Medical Group's current FCF Yield % is 11.71, which is near median its own 10-year median of 10.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pediatrix Medical Group stock overvalued right now?
Based on GuruFocus' analysis, Pediatrix Medical Group (FRA:PDC) is currently considered Significantly Overvalued. The stock's GF Value™ is €11.17, compared to a current price of €21.00 — trading 88% above its estimated fair value. The current FCF Yield % is 11.71, which is near median its 10-year median of 10.72 and 513.1% above the Healthcare Providers & Services industry median of 1.91. Pediatrix Medical Group's overall GF Score™ is 57/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Pediatrix Medical Group (FRA:PDC), the current FCF Yield % is 11.71 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pediatrix Medical Group (FRA:PDC) Overvalued in 2026?
Based on GuruFocus' analysis, Pediatrix Medical Group stock appears to be overvalued.
The current stock price of €21.00 is trading 88% above its estimated GF Value™ of €11.17.
GuruFocus considers Pediatrix Medical Group to be Significantly Overvalued.
Key valuation signals for FRA:PDC:
FCF Yield %: 11.71 (near median its 10-year median of 10.72)
GF Value™: €11.17 vs. price of €21.00 (88% above fair value)
Industry Position: 513.1% above the Healthcare Providers & Services median (#100 of 687)
No single metric tells the full story. See the FRA:PDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.
57GF Score
Get the complete analysis for FRA:PDC
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:PDC has been successfully added to your 
